Introduction
Rapidly renewed tissues such as bone marrow, gut and hair follicles are the most sensitive tissues in the human body to apoptosis induced by DNA damage. Gastrointestinal toxicity is the primary limiting factor in abdominal and pelvic radiotherapy, but has no effective treatment currently. Adult tissue stem cells are believed to be responsible for maintaining tissue homeostasis and regeneration after injury. Several elegant genetic studies in mice showed that Lgr5 (Barker et al., 2007) , CD133/ Prominin 1 (Zhu et al., 2009) and Bmi-1 (Sangiorgi and Capecchi, 2008) expressing cells at or near the crypt base are intestinal stem cells (ISCs). The cells in at least two locations show the properties of ISCs: the columnar cells at the crypt base (CBCs) and some þ 4 cells immediately above the Paneth cells. Work from us and others show that apoptosis in these cells is largely responsible for the acute intestinal damage and rapid onset of GI syndrome and death using a whole body radiation model (Potten, 2004; Ch'ang et al., 2005; Qiu et al., 2008) . Growth factors protect against radiation or chemotherapyinduced mucosal injury (Booth and Potten, 2001) . For example, insulin-like growth factor 1 (IGF-1), interleukin 11, keratinocyte growth factor, and fibroblast growth factor-2 (or basic fibroblast growth factor (bFGF-2)) have been shown to protect the þ 4 cells and increase animal survival after whole body radiation, but their targets and the underlying mechanism of intestinal protection are not well understood (Booth and Potten, 2001; Paris et al., 2001; Wilkins et al., 2002) .
The Bcl-2 family of proteins is evolutionarily conserved regulators of apoptosis, of which levels or activities are subjected to transcriptional or posttranslational regulation (Korsmeyer, 1999; Adams and Cory, 2007) . The BH3-only subgroup of proteins appear to initiate and promote apoptosis in a cell type-and stimulus-specific manner (Yu and Zhang, 2004; Labi et al., 2006) . Along with others, we identified p53 upregulated modulator of apoptosis (PUMA) as a BH3only protein and a transcriptional target of p53 that have an essential role in p53-dependent and -independent apoptosis through the mitochondrial pathway (Han et al., 2001; Nakano and Vousden, 2001; Yu et al., 2001) . The potent proapoptotic function of PUMA compared with most other BH3-only members perhaps rests in its ability to effectively neutralize all five known antiapoptotic Bcl-2-like proteins (Labi et al., 2006; Yu and Zhang, 2008) . Our work suggests PUMA as a major mediator of apoptosis in the intestinal epithelium in response to various genotoxic and nongenotoxic stresses (Yu et al., 2001 (Yu et al., , 2003 Wu et al., 2007; Ming et al., 2008; Qiu et al., 2008) . Our recent work indicated that PUMA deficiency protects the ISCs (both CBCs and þ 4 cells) and progenitors from radiation-induced apoptosis and improves crypt regeneration (Qiu et al., 2008) . The similar extent of apoptosis deficiency in the crypts of PUMA knockout (KO) and p53 KO mice suggests that PUMA is a mediator of the p53-dependent and radiation-induced apoptosis in the intestinal crypts and stem cells (Merritt et al., 1994; Komarova et al., 2004; Qiu et al., 2008) .
p53 regulates radiation-induced apoptosis in the crypts of the small intestine (Merritt et al., 1994; Komarova et al., 2004) . The phosphoinositide 3-kinase (PI3K)/ protein kinase B (AKT) pathway confers the antiapoptotic function of IGF-1 in various cell types (Butt et al., 1999) , and is also activated by bFGF in some cells (Katoh, 2006) . Connections between the p53 and IGF-1/AKT signaling pathways have been delineated in worms, flies, and mammals (Levine et al., 2006) . The PI3K/AKT pathway is activated by IGF-1 signaling, which leads to phosphorylation and activation of MDM2, and subsequent inactivation of p53 through the ubiquitin-proteasome system (Gottlieb et al., 2002; Levine et al., 2006) . Connections between p53 and bFGF signaling have also been described. For example, bFGF induced the synthesis of MDM2, leading to reduced activation of p53 and protection from DNAdamage-induced cell death in fibroblasts (Shaulian et al., 1997) . Fibroblast growth factor-1 was found to inhibit p53-dependent apoptosis in neuronal cells treated with etoposide (Bouleau et al., 2007) , whereas bFGF protected cultured endothelial cells from radiationinduced apoptosis (Gu et al., 2004) . However, whether there is a common mechanism for IGF-1 or bFGF and the PI3K/AKT/p53 pathway in radiation responses of the GI system remains to be elucidated.
Therefore, we hypothesize that inhibiting PUMAmediated apoptosis in the intestinal stem cells may be a common mechanism of growth factor-mediated intestinal radioprotection. In this study, we analyzed the role and mechanisms of PUMA in IGF-1 and bFGFmediated intestinal radioprotection. We showed that the suppression of PUMA has a critical role in IGF-1 and bFGF-mediated radioprotection in the GI system through a PI3K/AKT/p53-dependent mechanism.
Results

Growth factors protected against radiation-induced apoptosis in the intestinal crypts and stem cells
Using a whole body radiation model, we found that 15 Gy induced marked apoptosis in the intestinal crypts of wild-type (WT) mice at 24 h, which was blocked by 45 and 66% by three doses of IGF-1 and bFGF treatment, respectively ( Figures 1A and B , and Supplementary Figure S1a ). Using multicolor immunofluorescence, we determined the effects of these two growth factors specifically on the apoptosis of the CBCs, which reside at the bottom of the crypts in between Paneth cells that were stained positive for MMP-7 (Qiu et al., 2008) . It is noteworthy that IGF-1 or bFGF blocked the apoptosis in the CBCs by over 60% 24 h after radiation ( Figure 1C ). A microcolony assay was used to measure the regeneration capacity of intestinal stem cells 4 days after 15-Gy radiation, which gives an indirect yet functional measurement of the ISC survival. We found that IGF-1 or bFGF (3.5 mg/mouse) led to a nearly 2-fold (200%) increase in crypt regeneration ( Figure 1D and Supplementary Figure S1b) . A lower dose of IGF-1 treatment (1.8 mg/mouse) also significantly protected against radiation-induced apoptosis in the crypts and led to enhanced crypt regeneration (data not shown). To determine the effect of these factors on non-epithelial compartments, we examined the extent of apoptosis in the villus, which was similar 4 or 24 h after 15-Gy radiation regardless of IGF-1 or bFGF treatment (Supplementary Figure S1c and d, and data not shown).
Growth factors such as bFGF protect endothelial cells from radiation-induced apoptosis (Paris et al., 2001; Qiu et al., 2008) . Using double staining of the endothelial cell-specific marker CD105 and terminal deoxynucleotidyl transferase-mediated deoxyuridinetriphosphate nick end labeling (TUNEL), we confirmed that IGF-1 or bFGF inhibited endothelial cell apoptosis by 34 or 63%, respectively, at 4 h after 15-Gy radiation (Supplementary Figure S2a and b ). This correlated with slightly increased CD105 þ cell counts in the villi (Supplementary Figure S2c ). However, neither growth factor affected proliferation in the crypt at 4 or 24 h after radiation in WT mice or PUMA KO mice based on Ki67 staining (Supplementary Figure S3 ). These results indicate that IGF-1 and bFGF impaired radiationinduced and PUMA-dependent apoptosis in the stem cells and progenitors in the small intestine.
Growth factors reduced radiation-induced PUMA and p53 expression in the intestinal crypts
We then examined the effects of growth factor treatment on PUMA expression by real-time reverse transcriptase-PCR and western blotting in the intestinal mucosa of WT mice. PUMA messenger RNA was induced by approximately ninefold 4 h after 15-Gy whole body radiation, consistent with our earlier study (Qiu et al., 2008) . This induction was decreased by at least 60% with IGF-1 or bFGF treatment, respectively (Figure 2a ). The elevation of PUMA protein was evident 24 h after irradiation, which was significantly blocked by IGF-1 or bFGF treatment ( Figure 2b) . A lower dose of IGF-1 treatment (1.8 mg/mouse) also significantly suppressed PUMA induction by radiation in the intestinal mucosa (data not shown). We have earlier shown that radiation induces PUMA in the CBCs and þ 4 to þ 9 cells, which is p53 dependent (Qiu et al., 2008) . We therefore analyzed the levels of p53 and its target p21. We found that the induction of p53 and p21 was reduced by IGF-1 or bFGF treatment. Importantly, IGF-1 or bFGF did not further suppress crypt apoptosis or enhance crypt proliferation and regeneration in PUMA KO mice ( Supplementary Figures S3 and S4 ). The protection on ISCs against apoptosis provided by PUMA deficiency exceeds that by growth factors (Supplementary Figure S4 and Figure 1 ) (Qiu et al., 2008) , perhaps reflecting the residual p53 activity and resulting PUMA induction in the presence of either growth factor ( Figure 2) . These results show that IGF-1 or bFGF reduced radiation-induced PUMA and p53 expression in the intestinal crypts. Growth factors protected against radiation-induced apoptosis through the PI3K/AKT pathway in vitro To further elucidate the mechanisms of PUMA regulation by growth factors after radiation, we tested whether IGF-1 and bFGF are radioprotective in the colonic epithelial HCT116 cells that are deficient in p21. Our previous studies showed that radiation induces PUMAdependent apoptosis in these cells (Yu et al., 2003; Wang et al., 2007) . Radiation (15 Gy) induced approximately 60% apoptosis in HCT116 p21 KO cells 48 h after radiation, which was significantly blocked by IGF-1 and bFGF ( Figure 3a ). PUMA messenger RNA was induced by approximately sevenfold 24 h after radiation. However, the induction was blocked by over 70% by IGF-1 or bFGF treatment ( Figure 3b ). Consistently, the levels of PUMA protein were significantly inhibited ( Figure 3c ). Given an antiapoptotic role of the PI3K/ AKT pathway downstream of IGF-1 or bFGF signaling, we examined AKT activation. The levels of phosphorylated-AKT (p-AKT) were significantly elevated by IGF-1 or bFGF treatment ( Figure 3c ). We also examined a possible involvement of p38 and p44/42 mitogen-activated protein kinases. No change in p38 levels or phosphorylation, or only a small increase in phosphorylated p44/42 was detected in response to growth factors (Supplementary Figure S5 ). Furthermore, their inhibitors SB203580 and PD98059 did not significantly affect either PUMA induction or apoptosis induced by radiation (data not shown). In contrast, the pretreatment of PI3K inhibitor LY294002 reversed the inhibition of PUMA by either growth factor ( Figure 3d ). The patterns of p53 expression changes were similar to those of PUMA in these experiments (Figures 3c and d ). Furthermore, PUMA was found to be induced by radiation in HCT116 cells but not in p53 deficient (HCT116 p53 KO) or p53 mutant (DLD1) cells ( Figure 3e ). These data suggest that the regulation of PUMA by p53 through the PI3K/AKT pathway might be involved in growth factor-mediated radioprotection.
Growth factors inhibited PUMA and apoptosis induction by radiation through a p53-dependent mechanism in vitro To further probe this pathway, we overexpressed the dominant-negative PI3K (p85), which was found to abrogate AKT phosphorylation and restore the expression of PUMA and p53 with IGF-1 or bFGF treatment ( Figure 4a ). In contrast, a constitutive active form of AKT suppressed PUMA and p53 induction by radiation ( Figure 4b ). To further analyze the role of p53 in this process, we treated the HCT116 p21 KO cells with the Mdm2 antagonist nutlin-3a, which prevents ubiquitination-mediated degradation of p53 by disrupting the interaction of p53 from MDM2 (Gottlieb et al., 2002; Shangary and Wang, 2009 ). Nutlin-3a treatment led to stabilization of p53 and restored the induction of PUMA in the presence of either growth factor (Figure 4c ). Furthermore, growth factor-mediated suppression of radiation-induced apoptosis was significantly blocked by either LY294002 or nutlin-3a in these cells (Figure 4d ). Foxo3a can mediate PUMA induction in some immune cells in response to cytokine/ growth factor withdrawal . Interestingly, radiation was found to activate Foxo3a as suggested by decreased phosphorylation (Figure 4a ) (Yang et al., 2006) . However, knockdown of Foxo3a by small interference RNA had no effect on PUMA induction after radiation (Figure 4e ). These results suggest that activation of the PI3K/AKT pathway by growth factors blocks PUMA induction by radiation in colonic epithelial cells through p53, but not Foxo3a. Growth factors protected the intestinal stem cells from radiation-induced apoptosis through the PI3K-AKT-p53-PUMA axis To validate whether the mechanism of PUMA regulation by IGF-1 and bFGF described above operates in vivo, we examined p-AKT expression in the intestinal crypts by immunohistochemistry. The p-AKT was almost completely absent in the crypts in either the unirradiated or irradiated mice, whereas cytoplasmic p-AKT was greatly induced in the bottom of crypts and in the CBC area after IGF-1 or bFGF treatment (Figure 5a ). Using dual-color immnunohistochemistry, we found that the p-AKT was induced to high levels in the CBCs stained negative for MMP-7 ( Figure 5B ). Western blotting results also confirmed the induction of p-AKT in the intestinal mucosa ( Figure 5C ). The treatment of PI3K inhibitor LY294002 or the MDM2 antagonist nutlin-3a abrogated the protection against apoptosis in the CBCs and crypt cells afforded by growth factors (Figures 5C and D , Supplementary  Figures S6 and S7 ). Consistently, both LY294002 and nutlin-3a restored the induction of PUMA and p53 ( Figures 5C and D) . In addition, we also found that apoptosis in the CBCs was reduced more in PUMA KO mice than in p53 KO mice ( Figure 6 ). These data show that the suppression of PUMA induction through the PI3K/AKT/p53 axis in the intestinal stem cells is an important mechanism of growth factor-mediated intestinal radioprotection.
Discussion
A number of growth factors protect against radiation injury in the gut of mice, although the underlying molecular mechanisms are unclear (Booth and Potten, 2001; Wilkins et al., 2002) . A better understanding of such mechanisms is critical for developing strategies to preserve the normal functions of the GI tract upon radiation injury. Earlier studies suggested that the protective effects of growth factors in both the endothelial and epithelial compartments might be important (Booth and Potten, 2001; Paris et al., 2001; Wilkins et al., 2002) . This study shows PUMA as a critical target of IGF-1-and bFGF-mediated radioprotection in the intestinal stem cells and crypts. Both IGF-1 and bFGF reduced radiation-induced apoptosis and PUMA expression in the small intestinal crypts and stem cells, while they provided no additional protection in PUMA-deficient mice. Furthermore, our mechanistic data indicate the PI3K/AKT/p53 axis mediates PUMA suppression in response to growth factors in vitro and in vivo. These observations suggest that downregulation of PUMA is a common mechanism underlying intestinal radioprotection by growth factors. The PI3K/AKT pathway is a well-established antiapoptotic effector of the IGF-1 signaling (Levine et al., 2006) . Both the mitogen-activated protein kinase and PI3K/AKT pathways have been documented as downstream effectors of bFGF in promoting survival, although their relative contributions are not well understood (Katoh, 2006) . Our results showed that the PI3K/AKT pathway is activated by both IGF-1 and bFGF in the GI system to suppress the expression of a key apoptotic initiator, PUMA, after radiation. A slightly better protection against apoptosis was provided by bFGF in vitro and in vivo, which is correlated with a more efficient suppression of PUMA and p53. These observations are consistent with earlier ones in which bFGF enhanced radiation-induced crypt regeneration (Houchen et al., 1999) , and engaged the MDM2-p53 axis to promote the survival of fibroblasts (Shaulian et al., 1997) , and the enriched expression of fibroblast growth factor-R3 in the bottom of the crypts (Gulati et al., 2008) . Several mitogen-activated protein kinaserelated kinases such as JNK (Fuchs et al., 1998) and p38 (Sanchez-Prieto et al., 2000) family members have been shown to regulate p53 activities and genotoxic stressinduced apoptosis. However, we did not find definitive evidence for the involvement of either p38 or p44/42 in IGF-1 or bFGF-mediated protection against radiationinduced apoptosis or PUMA expression in HCT116 p21 KO cells. Our results suggest that the PI3K/AKT/p53 axis is likely to be a common mechanism of growth factor-mediated intestinal radioprotection, whereas PUMA-independent mechanisms in the protection of endothelial cells against apoptosis remain to be defined (Paris et al., 2001; Qiu et al., 2008) (Supplementary Figure S2 ).
PUMA has been reported to be regulated by survival and growth factors in cancer cells independently of p53 (Han et al., 2001; You et al., 2006; Ming et al., 2008) . This study together with our previous results show that PUMA induction by radiation is completely p53 dependent (Yu et al., 2003; Wang et al., 2007; Qiu et al., 2008) . Despite its regulation by radiation and growth factors, Foxo3a does not appear to be a main regulator of PUMA expression after radiation. p53 status is clearly important in the responses to genotoxic stresses in many types of normal cells in several ways (Vousden and Lu, 2002; Yu and Zhang, 2005) , and our data provide an explanation in the intestinal epithelium. p53 was firstly and serendipitously found to induce apoptosis after cytokine deprivation (Yonish-Rouach et al., 1991) , and later found to regulate apoptotic responses to a wide range of genotoxic and oncogenic stresses through transcriptional activation of its downstream targets (Vousden and Lu, 2002; Yu and Zhang, 2005) . Our data suggest that p53, as a central regulator of DNA-damage response, cleverly integrates signals from a variety of sources on DNA damage to determine cell fate. In intestinal stem cells, p53 is activated by the ATM/Chk2 pathway after radiation (Ch'ang et al., 2005) , whereas growth factors activate the PI3K/AKT pathway to suppress p53 through MDM2 (this study). The extent of p53-dependent PUMA induction largely determines the survival of intestinal stem cells and subsequent crypt regeneration. Similar mechanisms might operate in radiosensitive tissues such as thymocytes, which undergo p53 and PUMA-dependent apoptosis (Jeffers et al., 2003; Villunger et al., 2003) .
It is important to point out that crypt apoptosis is blocked at a similar extent in mice deficient in either p53 or PUMA, while crypt regeneration only increased in PUMA KO mice (Komarova et al., 2004; Qiu et al., 2008) . This would suggest mechanisms that are dependent on p53, but not PUMA, are also required for crypt regeneration. One possibility is that PUMA deficiency enhances the survival of the CBCs better than p53 deficiency ( Figure 6) .
Emerging evidence suggests that DNA-damage signaling and apoptosis in the stem cell compartment have key roles in intestinal injury and regeneration. A number of genes and pathways have been identified as regulators of radiation-induced GI damage and crypt cell apoptosis, including p53 (Merritt et al., 1994; Komarova et al., 2004) , ATM (Ch'ang et al., 2005) , PUMA (Qiu et al., 2008) , p21 (Komarova et al., 2004; George et al., 2009 ), p53BP1 (Clarke et al., 2007) and Poly (ADP-ribose) polymerase-1 (Ishizuka et al., 2003) . It is certainly possible that players other than p53 and PUMA are involved in growth factor-mediated intestinal radioprotection. Despite their well-documented growth promoting activities, the administrations of growth factors shortly before and after radiation in our studies would suggest that their antiapoptotic activities are perhaps more critical for intestinal radioprotection. However, our studies can not rule out the involvement of their other activities in the epithelial or endothelial compartment particularly when dosed differently (Booth and Potten, 2001; Paris et al., 2001; Wilkins et al., 2002) . Expression or activities of several other BH3-only proteins can be regulated by growth factors independently of p53 (Labi et al., 2006) ; whether any of them has a role in radiation-induced intestinal damage remains to be elucidated. In addition, the use of recently developed ISC lineage tracing models (Barker et al., 2007; Sangiorgi and Capecchi, 2008) will help better elucidate the critical regulators of the survival and regeneration of ISCs after injury.
In summary, we identified suppression of PUMA by the PI3K/AKT/p53 axis as a common mechanism underlying growth factor-mediated intestinal radioprotection. This provides potential targets for developing radiation mitigators or protectors that can selectively preserve intestinal stem cells to facilitate tissue regeneration. Targeting this pathway by small molecule PUMA inhibitors might provide benefits to cancer patients or victims of radiation poisoning.
Materials and methods
Mice and treatment
The procedures of all animal experiments were approved by the Institutional Animal Care and Use Committee at the University of Pittsburgh. In all, 8-to 10-week-old PUMA þ / þ (WT), PUMA À/À (PUMA KO) and p53 À/À (p53 KO) littermates (F6 on C57BL/6 background) were generated from heterozygote breeding. The mice were housed in micro-isolator cages in a room illuminated from 0700 to 1900 hours (12:12-hr lightdark cycle), and allowed access to water and chow ad libitum. Genotyping of WT, PUMA KO and p53 KO alleles were performed as described earlier (Wu et al., 2007) . Mice were irradiated at doses ranging from 0 to 18 Gy at a rate of 82 cGy/min using a 137 Cs irradiator (Mark I, JL Shepherd and Associates, San Fernando, CA, USA).
Growth factor treatment. Mice were injected intravenous with 3.5 mg human recombinant IGF-1 and 3.5 mg bFGF in three doses (1.17 mg/dose) delivered 30 min before, 5 min before and 30 min after radiation. In some experiments, mice were treated additionally 1 h after radiation with 10 mg/kg nutlin-3a (Sigma-Aldrich, St Louis, MO, USA) through intraperitoneal injection, or 1 h before the first dose of growth factor with 40 mg/kg LY294002 (Cayman Chemical, Ann Arbor, MI, USA) through intraperitoneal injections. Mice were killed to collect the small intestines for histology analysis and western blotting at 4 and/or 24 h after radiation. The experiment was repeated three times.
Terminal deoxynucleotidyl transferase-mediated deoxyuridinetriphosphate nick end labeling staining and crypt microcolony assay Both have been described earlier using 5 mm sections (Qiu et al., 2008) . In brief, after TUNEL staining, the number of TUNEL positive cells in each crypt was scored in 100 crypts per section and reported as mean ± s.e.m. Three mice were used in each group. The survival of ISCs was quantified by Growth factors suppress PUMA-mediated apoptosis W Qiu et al counting regenerated crypts 4 days after irradiation in hematoxylin and eosin stained cross sections. Surviving crypts were defined as containing five or more adjacent chromophilic non-Paneth cells, at least one Paneth cell and a lumen. The number of surviving crypts was counted in 5-10 circumferences per mouse, with each approximately 1 cm apart. Three mice were used in each group.
Immunohistochemistry and immunoflourescence p-AKT and Ki67 immunohistochemistry. Immunohistochemistry was performed as described earlier (Qiu et al., 2008) . In brief, sections were deparaffinized, rehydrated and treated with 3% hydrogen peroxide. After antigen retrieval, sections were blocked with 10% goat serum for 30 min at RT. The sections were incubated with rabbit anti-p-AKT antibody (Cell Signaling, Beverly, MA, USA) or rat anti-Ki67 antibody (DAKO, Carpinteria, CA, USA) diluted 1:100 overnight at 4 1C. The signal was detected using the Envision kit (DAKO, Carpinteria, CA). The sections were counter stained with hematoxylin.
p-AKT/MMP-7 double staining
The p-AKT staining was performed as above without the counter stain followed by MMP-7 staining as described (Qiu et al., 2008) . The sections were then incubated with mouse anti-MMP-7 antibody (eBioscience, San Diego, CA, USA) at 1:100 dilutions overnight at 4 1C. The signals were detected with the biotinylated secondary antibodies (Pierce, Rockford, IL, USA), and developed by alkaline phosphatase streptavidin (SA-AP) (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) and BCIP/NBT liquid substrate system (Sigma-Aldrich) following the manufacturer's instructions.
TUNEL/MMP-7/DAPI multicolor IF Terminal deoxynucleotidyl transferase-mediated deoxyuridinetriphosphate nick end labeling staining was performed using the ApopTags Plus IFC In Situ Apoptosis Detection Kit (Millipore, Billerica, MA, USA). Antigen retrieval was performed after TUNEL staining in 0.1 M Citrate Buffer Antigen Retrieval Solution (pH 6.0) as described above. The sections were blocked with 20% goat or rabbit serum for 30 min at RT and then incubated with mouse anti-MMP-7 antibody (eBioscience) at a 1:100 dilution overnight at 4 1C. The signals were detected with the biotinylated secondary antibodies (Pierce), and developed by Alexa 594 Streptavidin (Invitrogen, Carlsbad, CA, USA) following the manufacturer's instructions. The sections were mounted with VECTASHIELD Mounting Medium with DAPI (Vector Laboratories, Burlingame, CA, USA).
Cell culture, treatment and expression constructs
The human colorectal cancer cell line DLD1, HCT116 (ATCC, Manassas, VA, USA), the p21-targeted HCT116 p21 KO (Waldman et al., 1995) , and p53-targeted HCT116 p53 KO cells (Bunz et al., 1998) were cultured in McCoy's 5A modified medium (Invitrogen) supplemented with 10% defined fetal bovine serum (HyClone, Logan, UT, USA), 100 units/ml penicillin and 100 mg/ml streptomycin (Invitrogen). Cells were maintained at 37 1C with 5% CO 2 . Cells were plated in 12-well plates at 20-30% density 24 h before treatment with 1% serum. IGF-1 (100 ng/ml) and bFGF (400 ng/ml) (Pepro Tech, Rocky Hill, NJ, USA) were added into medium 1 h before 15-Gy irradiation. The medium was changed with freshly added IGF-1 and bFGF 1 h after IR. Cells were irradiated at a rate of 82 cGy/min using a 137 Cs irradiator (Mark I, JL Shepherd and Associates). In some experiments, 50 mM LY294002 was added to cells 1 h before IGF-1 or bFGF treatment, or 10 mM nutlin-3a was added 8 h after IR. The cells were collected and analyzed for protein expression and apoptosis at 24 and 48 h after IR, respectively. The AKT dominant-negative PI3K (p85) expression plasmids have been described earlier (Sun et al., 2009) . Cells were transfected with Lipofectamine 2000 (Invitrogen) according to the manufacture's instructions and subjected to radiation 24 h after transfection.
Knockdown of Foxo3a by small interference RNA HCT116 p21 KO cells were transfected with ON-TARGETplus Duplex small interference RNA specific for Foxo3a (J-003007-10; Dharmacon, Lafayette, CO, USA) or the control scrambled small interference RNA by Lipofectamine 2000 (Invitrogen). The cells were irradiated with 15 Gy and harvested 24 h later for analysis.
Nuclear fragmentation assay
Apoptosis of the cultured cells was quantified by nuclear fragmentation assay. Both attached and floating cells were harvested at various time points after the treatment. Apoptosis was analyzed by counting cells with condensed chromatin and micronucleation after nuclear staining with Hoechst 33258 as described (Yu et al., 1999; Kohli et al., 2004) . A minimum of 300 cells were analyzed in triplicate.
Total RNA extraction and real-time reverse transcriptase-PCR Total RNA and complementary DNA were prepared from freshly scraped intestinal mucosa as described (Qiu et al., 2008) . The primers used for PUMA and b-actin have been described (Qiu et al., 2008) . Real-time PCR was performed on a Mini Opticon Real-time PCR System (BioRad, Hercules, CA, USA) with SYBR Green (Invitrogen). Three mice were used in each group. Melting curve and agarose gel electrophoresis of the PCR product were used to verify the specificity of PCR amplification.
Western blotting and antibodies
Cell lysates were collected and western blotting was performed as described (Yu et al., 2003) . The antibodies used for western blotting included antibodies against human PUMA (Yu et al., 2003) , p53 (DO1) (Santa Cruz Biotechnologies, Santa Cruz, CA, USA), p21, a-tubulin (EMD Biosciences, San Diego, CA, USA), human and mouse phospho-AKT (Ser473, p-AKT), total-AKT, p38, p-p38 (Thr180/Tyr182), p44/42, p-p44/42 (Thr202/Tyr204), p-MDM2 (Ser166), c-Myc, p-Foxo3a (Thr32) (Cell Signaling), Foxo3a (Millipore), MDM2 (Santa Cruz), and antibodies against mouse PUMA (Abcam, Cambridge, MA, USA), p53, p21 (Santa Cruz) and b-actin (Sigma).
Statistical analysis
Statistical analysis was carried out using GraphPad Prism IV software. P-values were calculated by the Student's t-test. P-values o0.05, indicating the probability of the difference occurring by chance was o5 in 100, were considered significant. The means ± one s.d. were shown in the figures where applicable.
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